Dr. Moshe Frenkel is a clinical associate professor at the University of Texas Medical Branch and founder of the Integrative Medicine Clinic, at The University of Texas M. D. Anderson Cancer Center, Houston Texas.
Dr. Frenkel is Board certified in Family Practice, earned his medical degree from Sackler School of Medicine, Tel Aviv University, Israel and completed his family practice residency at Brookhaven Memorial Hospital Medical Center in Patchogue, New York, an affiliate of Stony Brook University. Prior to joining M.D. Anderson Cancer Center he was serving as a faculty in University of Texas Medical Branch at Galveston and served as a key contributor to an NIH grant on integrating Complementary and Integrative Medicine (CIM) into the medical school curriculum, as well as providing CIM consultations to patients and families.
Up to 2009 Dr Frenkel was the medical director of the Integrative Medicine Program, Department of Palliative Care and Rehabilitation Medicine at The University of Texas M. D. Anderson Cancer Center. He was working with a multidisciplinary team and provided clinical consultations and integrative medicine treatments for patients and their families who wish to have complementary and integrative medicine (CIM) become part of their cancer care. He has published over 70 papers in peer reviewed journals, coauthored chapters on integrative medicine and cancer care in multiple leading oncology textbooks and developed and implemented research projects related to integrative medicine. The main focus of his research activity were the rational integration of complementary medicine into the conventional medical education and clinical practice, and integrating the patients perspective into the regular care.
Since 2011 Dr Frenkel is directing an integrative oncology service in Meir Medical Center in Israel as well as being involved in private practice. He serves as the chair of the Israeli Society of Complementary Medicine which is part of the Israel Medical Association. He chairs the clinical practice committee of The Society of Integrative Oncology as well as being an active member of the clinical working group and the oncology subgroup of The Consortium of Academic Health Centers for Integrative Medicine, which includes 57 U.S. academic medical centers such as Harvard, Duke, Georgetown and others.